Diagnostic Imaging's Weekly Scan: August 11 — August 17 (Video Version)

Welcome to Diagnostic Imaging’s Weekly Scan, which offers an opportunity to catch up on the most well-viewed radiology content of the past week. Earlier this week, the Journal of Nuclear Medicine published research revealed that having PSMA PET/CT scans before salvage radiotherapy resulted in higher rates of survival and biomechanical recurrence-free survival at one, three and five years. In an interview with Diagnostic Imaging, neuroradiologist Tammie Benzinger discussed the utility of low-field MRI in facilitating appropriate triage and health equity for patients with suspected Alzheimer’s disease. In a new digital breast tomosynthesis (DBT) study published in the European Journal of Radiology, researchers found a 78 percent malignancy rate when DBT images showed a combination of architectural distortion with highly suspicious masses or microcalcifications. In the second part of a Reading Room Podcast on emerging trends in theranostics for prostate cancer, Jeremie Calais, M.D., Ph.D., discussed the potential of alpha-emitting therapies. Here is a clip from the podcast. Earlier this week, the FDA granted 510(k) clearance for the NeedleVue LC1 ultrasound system. While traditional ultrasound guidance for interventional procedures can be thwarted by complex calibration and reduced sensitivity, the multidirectional design with the NeedleVue LC1 Ultrasound System reportedly allows high-fidelity tracking from a variety of orientations. Watch the video summary below of Diagnostic Imaging’s Weekly Scan.